Crossref journal-article
Elsevier BV
Gene (78)
Bibliography

Ray, R. B., & Steele, R. (1997). Separate domains of MBP-1 involved in c-myc promoter binding and growth suppressive activity. Gene, 186(2), 175–180.

Authors 2
  1. Ratna B Ray (first)
  2. Robert Steele (additional)
References 23 Referenced 12
  1. Adnane, J., Zhaohui, S. and Robbins, P.D. (1995) The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J. Biol. Chem. 270, 8837–8843. (10.1074/jbc.270.15.8837)
  2. Bargonetti, J., Manfredi, J.J., Chen, X., Marshak, D.R. and Prives, C. (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev. 7, 2565–2574. (10.1101/gad.7.12b.2565)
  3. Chaudhary, D. and Miller, D.M. (1995) The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously in the minor groove of the c-myc P2 promoter. Biochemistry 34, 3438–3445. (10.1021/bi00010a036)
  4. Cole, M.D. (1986) The myc oncogene: Its role in transformation and differentiation. Annu. Rev. Genet. 20, 361–384. (10.1146/annurev.ge.20.120186.002045)
  5. Fields, S. and Jang, S.K. (1990) Presence of a potent transcription activating sequence in the p53 protein. Science 249, 1046–1049. (10.1126/science.2144363)
  6. Hamburger, A.W. and Salmon, S.E. (1980) Development of a bioassay for human myeloma colony-forming cells. Prog. Clin. Biol. Res. 48, 23–41.
  7. Hunter, T. and Karin, M. (1992) The regulation of transcription by phosphorylation. Cell 70, 375–387. (10.1016/0092-8674(92)90162-6)
  8. Kim, S.J., Wagner, S., O'Reilly, M.A., Lui, F., Robbins, P.D. and Green, M.R. (1994) Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 358, 331–334. (10.1038/358331a0)
  9. Lee, J.-S., Galvin, K.M. and Shi, Y. (1993) Evidence of physical interaction between the zinc-finger transcription factors YY1 and Sp1. Proc. Natl. Acad. Sci. USA 90, 6145–6149. (10.1073/pnas.90.13.6145)
  10. Lewis, B.A., Tullis, G., Seto, E., Horikoshi, N., Weinmann, R. and Shenk, T. (1995) Adenovirus E1A proteins interact with the cellular YY1 transcription factor. J. Virol. 69, 1628–1636. (10.1128/jvi.69.3.1628-1636.1995)
  11. Lin, J., Chen, J., Elenbaas, B. and Levine, A.J. (1994) Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8, 1235–1246. (10.1101/gad.8.10.1235)
  12. Pellegata, N.S., Cajot, J.-F. and Stanbridge, E.J. (1995) The basic carboxy-terminal domain of human p53 is dispensable for both transcriptional regulation and inhibition of tumor cell growth. Oncogene 11, 337–349.
  13. Ray, R. and Miller, D.M. (1991) Cloning and characterization of a human c-myc promoter-binding protein. Mol. Cell. Biol. 11, 2154–2161. (10.1128/mcb.11.4.2154-2161.1991)
  14. Ray, R., Thomas, S. and Miller, D.M. (1989) Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice. Oncogene 4, 593–600.
  15. Ray, R., Shrestha, K. and Miller, D.M. (1994) Cloning and characterization of MBP-2, a c-myc promoter binding protein. Int. J. Oncol. 5, 111–115.
  16. Ray, R.B. (1995) Induction of cell death in murine fibroblasts by a c-myc promoter binding protein. Cell Growth Diff. 6, 1089–1096.
  17. Ray, R.B., Steele, R., Seftor, E. and Hendrix, M. (1995) Human breast carcinoma cells transfected with the gene encoding c-myc promoter binding protein (MBP-1) shows tumor suppression in nude mice. Cancer Res. 55, 3747–3751.
  18. Raycroft, L., Wu, H. and Lozano, G. (1990) Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249, 1049–1051. (10.1126/science.2144364)
  19. Seto, E., Shi, Y. and Shenk, T. (1991) YYI is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature 354, 241–245. (10.1038/354241a0)
  20. Shaulian, E., Haviv, I., Shaul, Y. and Oren, M. (1995) Transcriptional repression by the C-terminal domain of p53. Oncogene 10, 671–680.
  21. Spencer, C.A. and Gourdine, M. (1991) Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 53, 1–48. (10.1016/S0065-230X(08)60476-5)
  22. Wang, Y., Reed, M., Wang, P., Stenger, J.E., Mayr, G., Anderson, M.E., Schwedes, J.F. and Tegtmeyer, P. (1993) p53 domains: Identification and characterization of two autonomous DNA-binding regions. Genes Dev. 7, 2575–2586. (10.1101/gad.7.12b.2575)
  23. Weintraub, S.J., Chow, K.N.B., Luo, R.X., Zhang, S.H., He, S. and Dean, D.C. (1995) Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375, 812–815. (10.1038/375812a0)
Dates
Type When
Created 23 years, 1 month ago (July 25, 2002, 3:20 p.m.)
Deposited 3 years, 2 months ago (June 30, 2022, 8:31 a.m.)
Indexed 2 months ago (July 4, 2025, 6:06 a.m.)
Issued 28 years, 7 months ago (Feb. 1, 1997)
Published 28 years, 7 months ago (Feb. 1, 1997)
Published Print 28 years, 7 months ago (Feb. 1, 1997)
Funders 1
  1. National Cancer Institute 10.13039/100000054

    Region: Americas

    gov (National government)

    Labels4
    1. Instituto Nacional del Cáncer
    2. National Cancer Institute at the National Institutes of Health
    3. Instituto Nacional del Cáncer de los Institutos Nacionales de la Salud
    4. NCI

@article{Ray_1997, title={Separate domains of MBP-1 involved in c-myc promoter binding and growth suppressive activity}, volume={186}, ISSN={0378-1119}, url={http://dx.doi.org/10.1016/s0378-1119(96)00693-2}, DOI={10.1016/s0378-1119(96)00693-2}, number={2}, journal={Gene}, publisher={Elsevier BV}, author={Ray, Ratna B and Steele, Robert}, year={1997}, month=feb, pages={175–180} }